Please login to the form below
Illumina
This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.
Loxo, Bayer get FDA okay for biomarker-driven cancer drug
To try to address the diagnostic issue, Loxo formed a partnership earlier this year with Illumina to develop a simple test – called TruSight Tumour 170 – that will use sequencing to identify
Latest news
-
UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
There’s no question that ONT needs to build scale quickly if it is to take on the likes of Illumina, which reported sales of $2.75bn last year compared to ... is not as accurate or high-throughput as Illumina’s, and the latter will continue to
-
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug
To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether
-
Daily Brief: Calls for early Brexit deal for science and innovation, Gottlieb threatens to name and shame
Genomics. Illumina buys genome data analysis firm. Genome sequencing leader Illumina has paid $100m for Edico Genome, a company which has developed software to speed-up the reading of genetic data. ... President of Product Development at Illumina.
-
Roche buys gene sequencing firm
Illumina to the altar. ... which is predicted to swell to $8.7bn by 2020 but at the moment is still dominated by Illumina with around 75% market share,.
-
AstraZeneca joins Genomics England consortium
Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines. . ... It joins another of other firms, including Biogen and Illumina, who have signed up to the project.
More from news
Approximately 7 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Pharma deals during July 2013
Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.
-
What can pharma learn from Olympic sports coverage?
So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Illumina expands board of directors
John Thompson brings experience from IBM and Microsoft. San Diego, US-based Illumina has appointed John Thompson to its board of directors. ... Francis de Souza, president and chief executive of Illumina, said: “John brings a great breadth of knowledge
-
GlobalData makes Americas appointment
He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
-
Why is the UK lagging behind the rest of Europe in cancer survival?
To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
-
Senior Medical Writer
-
Competitive salary and benefits
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Director – Healthcare PR
-
Salary TBC
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
